CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.0467
1.95%
Market Trading Hours* (UTC) Opens on Monday at 01:00

Mon - Fri: 01:00 - 04:00 05:00 - 09:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.0166
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.021416 %
Charges from full value of position ($-4.07)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.021416%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000502 %
Charges from full value of position ($-0.10)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000502%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency SGD
Margin 5%
Stock exchange Singapore
Commission on trade 0%

*Information provided by Capital.com

Raffles Medical Group Ltd ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 1.0267
Open* 1.0367
1-Year Change* -27.27%
Day's Range* 1.0367 - 1.0467
52 wk Range 1.01-1.52
Average Volume (10 days) 806.46K
Average Volume (3 months) 37.52M
Market Cap 1.96B
P/E Ratio 13.51
Shares Outstanding 1.86B
Revenue 755.08M
EPS 0.08
Dividend (Yield %) 3.65385
Beta 0.77
Next Earnings Date Feb 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 23, 2024 1.0467 0.0000 0.00% 1.0467 1.0467 1.0367
Feb 22, 2024 1.0367 0.0100 0.97% 1.0267 1.0367 1.0267
Feb 21, 2024 1.0267 -0.0200 -1.91% 1.0467 1.0467 1.0267
Feb 19, 2024 1.0367 0.0000 0.00% 1.0367 1.0367 1.0367
Feb 16, 2024 1.0267 0.0099 0.97% 1.0168 1.0267 1.0168
Feb 14, 2024 1.0068 0.0149 1.50% 0.9919 1.0068 0.9918
Feb 13, 2024 1.0068 0.0000 0.00% 1.0068 1.0168 1.0068
Feb 9, 2024 1.0068 0.0000 0.00% 1.0068 1.0168 1.0068
Feb 7, 2024 1.0168 0.0000 0.00% 1.0168 1.0267 1.0168
Feb 6, 2024 1.0168 0.0100 0.99% 1.0068 1.0168 1.0068
Feb 2, 2024 1.0068 -0.0100 -0.98% 1.0168 1.0168 1.0068
Feb 1, 2024 0.9968 -0.0100 -0.99% 1.0068 1.0068 0.9968
Jan 31, 2024 1.0068 0.0100 1.00% 0.9968 1.0068 0.9968
Jan 30, 2024 1.0068 0.0000 0.00% 1.0068 1.0068 1.0068
Jan 29, 2024 1.0068 0.0000 0.00% 1.0068 1.0168 1.0068
Jan 26, 2024 1.0168 0.0000 0.00% 1.0168 1.0168 1.0068
Jan 24, 2024 1.0168 0.0100 0.99% 1.0068 1.0168 1.0068
Jan 23, 2024 1.0068 -0.0199 -1.94% 1.0267 1.0267 1.0068
Jan 22, 2024 1.0267 0.0000 0.00% 1.0267 1.0367 1.0267
Jan 19, 2024 1.0267 -0.0100 -0.96% 1.0367 1.0467 1.0267

Raffles Medical Events

Time (UTC) Country Event
Monday, February 26, 2024

Time (UTC)

00:30

Country

SG

Event

Full Year 2023 Raffles Medical Group Ltd Earnings Release
Full Year 2023 Raffles Medical Group Ltd Earnings Release

Forecast

-

Previous

-
Friday, April 26, 2024

Time (UTC)

07:30

Country

SG

Event

Raffles Medical Group Ltd Annual Shareholders Meeting
Raffles Medical Group Ltd Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 766.537 723.791 568.203 522.038 489.135
Revenue 766.537 723.791 568.203 522.038 489.135
Cost of Revenue, Total 126.556 143.27 135.775 110.969 99.518
Gross Profit 639.981 580.521 432.428 411.069 389.617
Total Operating Expense 570.691 602.485 479.761 445.87 404.9
Selling/General/Admin. Expenses, Total 344.56 390.212 295.637 274.059 259.514
Depreciation / Amortization 40.216 39.326 35.495 29.26 18.273
Other Operating Expenses, Total 42.147 36.147 12.854 31.582 30.99
Operating Income 195.846 121.306 88.442 76.168 84.235
Interest Income (Expense), Net Non-Operating -4.142 -5.722 -4.003 -0.244 -0.101
Net Income Before Taxes 191.704 115.584 84.439 75.924 84.134
Net Income After Taxes 143.702 83.716 64.67 60.522 70.803
Minority Interest -0.186 0.455 1.221 -0.249 0.253
Net Income Before Extra. Items 143.516 84.171 65.891 60.273 71.056
Net Income 143.516 84.171 65.891 60.273 71.056
Income Available to Common Excl. Extra. Items 143.516 84.171 65.891 60.273 71.056
Income Available to Common Incl. Extra. Items 143.516 84.171 65.891 60.273 71.056
Diluted Net Income 143.516 84.171 65.891 60.273 71.056
Diluted Weighted Average Shares 1866.35 1876.46 1840.37 1815.81 1788.29
Diluted EPS Excluding Extraordinary Items 0.0769 0.04486 0.0358 0.03319 0.03973
Dividends per Share - Common Stock Primary Issue 0.038 0.018 0.025 0.025 0.025
Diluted Normalized EPS 0.0843 0.04433 0.03794 0.03326 0.04
Interest Expense (Income) - Net Operating -3.395
Unusual Expense (Income) 17.212 -6.47
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 370.85 384.233 409.739 379.976 343.815
Revenue 370.85 384.233 409.739 379.976 343.815
Cost of Revenue, Total 92 65.467 77.057 72.129 71.141
Gross Profit 278.85 318.766 332.682 307.847 272.674
Total Operating Expense 294.184 274.764 323.517 314.733 287.752
Selling/General/Admin. Expenses, Total 163.291 146.85 197.71 205.197 185.015
Depreciation / Amortization 19.022 19.59 20.626 20.846 18.48
Interest Expense (Income) - Net Operating
Unusual Expense (Income) 17.296
Other Operating Expenses, Total 19.871 25.561 28.124 16.561 13.116
Operating Income 76.666 109.469 86.222 65.243 56.063
Interest Income (Expense), Net Non-Operating 1.76 -1.248 -2.894 -3.25 -2.472
Net Income Before Taxes 78.426 108.221 83.328 61.993 53.591
Net Income After Taxes 60.417 83.74 59.833 44.876 38.84
Minority Interest -0.566 0.105 -0.291 -0.15 0.605
Net Income Before Extra. Items 59.851 83.845 59.542 44.726 39.445
Net Income 59.851 83.845 59.542 44.726 39.445
Income Available to Common Excl. Extra. Items 59.851 83.845 59.542 44.726 39.445
Income Available to Common Incl. Extra. Items 59.851 83.845 59.542 44.726 39.445
Diluted Net Income 59.851 83.845 59.542 44.726 39.445
Diluted Weighted Average Shares 1870.14 1863.62 1869.07 1882.52 1870.4
Diluted EPS Excluding Extraordinary Items 0.032 0.04499 0.03186 0.02376 0.02109
Dividends per Share - Common Stock Primary Issue 0 0.038 0 0.018 0
Diluted Normalized EPS 0.03206 0.05266 0.03188 0.02425 0.01858
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 460.257 439.099 331.13 246.006 198.525
Cash and Short Term Investments 253.127 264.988 203.114 151.826 105.984
Cash & Equivalents
Total Receivables, Net 194.032 160.737 113.429 83.935 83.221
Accounts Receivable - Trade, Net 194.032 160.737 113.429 83.935 83.221
Total Inventory 13.098 13.374 14.587 10.245 9.32
Total Assets 1497.7 1545.29 1404.13 1284.82 1116.29
Property/Plant/Equipment, Total - Net 739.072 797.362 739.905 685.585 565.716
Property/Plant/Equipment, Total - Gross 908.471 959.927 879.784 819.76 674.788
Accumulated Depreciation, Total -169.399 -162.565 -139.879 -134.175 -109.072
Goodwill, Net 11.15 18.322 21.233 23.835 24.423
Intangibles, Net 9.124 13.508 12.911 13.619 12.864
Long Term Investments 273.4 274 294.6 311.16 311.16
Note Receivable - Long Term 2.274 1.857 3.285 3.452 2.59
Other Long Term Assets, Total 2.425 1.138 1.07 1.165 1.011
Total Current Liabilities 325.7 416.611 279.924 218.953 186.329
Payable/Accrued 223.771 253.568 191.382 162.53 136.789
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 19.326 106.54 38.736 19.301 19.307
Other Current Liabilities, Total 82.603 56.503 49.806 37.122 30.233
Total Liabilities 482.648 584.492 505.138 443.929 315.8
Total Long Term Debt 76.817 91.592 166.157 181.075 97.189
Long Term Debt 63.376 77.914 143.859 156.559 97.189
Deferred Income Tax 8.303 10.147 7.746 7.014 4.765
Minority Interest 15.35 15.826 15.401 15.961 16.137
Other Liabilities, Total 56.478 50.316 35.91 20.926 11.38
Total Equity 1015.05 960.794 898.996 840.893 800.489
Common Stock 432.379 426.346 420.966 393.47 365.332
Retained Earnings (Accumulated Deficit) 606.22 512.222 463.172 441.519 424.921
Unrealized Gain (Loss) 16.367 16.367 16.367 16.367 16.367
Other Equity, Total -13.018 9.089 -1.109 -10.063 -6.131
Total Liabilities & Shareholders’ Equity 1497.7 1545.29 1404.13 1284.82 1116.29
Total Common Shares Outstanding 1854.55 1868.29 1864.73 1827.94 1797.17
Cash 83.159 99.152 44.753 52.108 61.406
Short Term Investments 169.968 165.836 158.361 99.718 44.578
Capital Lease Obligations 13.441 13.678 22.298 24.516
Treasury Stock - Common -26.894 -3.23 -0.4 -0.4
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 503.907 460.257 432.309 439.099 358.517
Cash and Short Term Investments 300.695 253.127 289.067 264.988 215.741
Cash & Equivalents 300.695 253.127 289.067 264.988 215.741
Total Receivables, Net 190.298 194.032 130.682 160.737 128.279
Accounts Receivable - Trade, Net 190.298 194.032 130.682 160.737 128.279
Total Inventory 12.914 13.098 12.56 13.374 14.497
Total Assets 1522.81 1497.7 1518.86 1545.29 1455.09
Property/Plant/Equipment, Total - Net 720.022 739.072 777.775 797.362 763.52
Intangibles, Net 7.987 9.124 12.136 31.83 35.132
Long Term Investments 273.4 273.4 274 274 294.6
Note Receivable - Long Term 2.348 2.274 3.313 1.857 2.172
Other Long Term Assets, Total 4.3 2.425 1.243 1.138 1.147
Total Current Liabilities 414.694 325.7 404.253 416.611 318.25
Payable/Accrued 260.517 223.771 243.622 253.568 207.487
Notes Payable/Short Term Debt 87.656 0 0 0 0
Current Port. of LT Debt/Capital Leases 21.4 19.326 86.224 106.54 49.177
Other Current Liabilities, Total 45.121 82.603 74.407 56.503 61.586
Total Liabilities 523.871 482.648 573.114 584.492 544.256
Total Long Term Debt 71.594 76.817 89.623 91.592 162.65
Long Term Debt 60.312 63.376 77.914 77.914 145.036
Capital Lease Obligations 11.282 13.441 11.709 13.678 17.614
Deferred Income Tax 9.418 8.303 10.615 10.147 7.68
Minority Interest 15.747 15.35 16.093 15.826 15.358
Other Liabilities, Total 12.418 56.478 52.53 50.316 40.318
Total Equity 998.941 1015.05 945.745 960.794 910.832
Common Stock 438.623 432.379 430.777 426.346 423.176
Retained Earnings (Accumulated Deficit) 594.613 606.22 521.306 512.222 466.228
Treasury Stock - Common -26.894 -26.894 -26.787 -3.23 0
Unrealized Gain (Loss) 16.367 16.367 16.367 16.367 16.367
Other Equity, Total -23.768 -13.018 4.082 9.089 5.061
Total Liabilities & Shareholders’ Equity 1522.81 1497.7 1518.86 1545.29 1455.09
Total Common Shares Outstanding 1860.33 1854.55 1852.44 1868.29 1867.56
Goodwill, Net 10.848 11.15 18.083
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 143.702 83.716 64.67 60.522 70.803
Cash From Operating Activities 196.225 160.112 133.146 111.147 91.528
Cash From Operating Activities 37.513 36.725 33.487 27.65 17.172
Amortization 2.703 2.601 2.008 1.61 1.101
Non-Cash Items 74.315 44.642 34.985 15.06 12.069
Cash Taxes Paid 29.146 21.742 9.705 12.488 12.694
Cash Interest Paid 6.796 7.305 6.025 4.857 2.03
Changes in Working Capital -62.008 -7.572 -2.004 6.305 -9.617
Cash From Investing Activities -22.832 -52.199 -62.189 -96.871 -102.656
Capital Expenditures -25.299 -52.804 -60.064 -98.379 -31.407
Other Investing Cash Flow Items, Total 2.467 0.605 -2.125 1.508 -71.249
Cash From Financing Activities -183.702 -46.873 -20.878 31.547 20.076
Financing Cash Flow Items -6.796 -7.305 -6.025 -4.857 -2.413
Total Cash Dividends Paid -52.015 -37.349 -19.186 -17.954 -15.63
Issuance (Retirement) of Stock, Net -18.311 2.365 0.778 0.582 0.771
Issuance (Retirement) of Debt, Net -106.58 -4.584 3.555 53.776 37.348
Foreign Exchange Effects -1.545 0.811 1.229 -1.058 -1.234
Net Change in Cash -11.854 61.851 51.308 44.765 7.714
Dec 2022 Jun 2022 Dec 2021 Jun 2021 Dec 2020
Net income/Starting Line 143.702 59.962 83.716 38.84 64.67
Cash From Operating Activities 196.225 134.9 160.112 83.183 133.146
Cash From Operating Activities 37.513 19.265 36.725 17.345 33.487
Amortization 2.703 1.361 2.601 1.135 2.008
Non-Cash Items 74.315 27.966 44.642 18.355 34.985
Cash Taxes Paid 29.146 14.588 21.742 11.505 9.705
Cash Interest Paid 6.796 3.524 7.305 3.455 6.025
Changes in Working Capital -62.008 26.346 -7.572 7.508 -2.004
Cash From Investing Activities -22.832 -11.363 -52.199 -40.441 -62.189
Capital Expenditures -25.299 -11.811 -52.804 -40.711 -60.064
Other Investing Cash Flow Items, Total 2.467 0.448 0.605 0.27 -2.125
Cash From Financing Activities -183.702 -99.078 -46.873 -30.648 -20.878
Financing Cash Flow Items -6.796 -3.524 -7.305 -3.455 -6.025
Total Cash Dividends Paid -52.015 -52.015 -37.349 -37.349 -19.186
Issuance (Retirement) of Stock, Net -18.311 -19.126 2.365 2.504 0.778
Issuance (Retirement) of Debt, Net -106.58 -24.413 -4.584 7.652 3.555
Foreign Exchange Effects -1.545 -0.413 0.811 0.514 1.229
Net Change in Cash -11.854 24.046 61.851 12.608 51.308
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Raffles Medical Holdings Pte. Ltd. Corporation 38.1805 719394504 0 2023-03-21 LOW
Loo (Choon Yong) Individual Investor 10.7473 202500534 0 2023-03-21 LOW
Global Alpha Capital Management Ltd. Investment Advisor 8.9571 168768350 0 2023-03-21 LOW
S & D Holdings Pte. Ltd. Corporation 3.3306 62755366 0 2023-10-05 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.3986 26351915 187300 2023-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.897 16901331 -80493 2022-12-31 LOW
Tan (Tiang Lee) Individual Investor 0.8344 15721192 304000 2023-03-21
Asian Medical Foundation Ltd. Corporation 0.7666 14443321 0 2023-03-21
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.6348 11961100 52000 2023-09-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.6277 11826234 65700 2023-09-30 LOW
Florida State Board of Administration Pension Fund 0.5846 11014211 -1268171 2022-09-30 LOW
Yii (Hee Seng) Individual Investor 0.5148 9700513 0 2023-03-21
Tan (Soo Nan) Individual Investor 0.2479 4671000 5000 2023-10-05 LOW
Baillie Gifford & Co. Investment Advisor 0.2461 4636995 0 2023-07-31 LOW
Schroder Investment Management (Singapore) Ltd. Investment Advisor/Hedge Fund 0.2424 4568152 0 2023-05-31 LOW
Public Mutual Berhad Investment Advisor 0.2364 4455000 -10000 2023-02-28 LOW
J O Hambro Capital Management Limited Investment Advisor/Hedge Fund 0.2343 4413900 -182100 2023-04-30 MED
1832 Asset Management L.P. Investment Advisor 0.2279 4294600 0 2023-05-31 LOW
Manulife Investment Management (North America) Limited Investment Advisor 0.2159 4067200 0 2023-09-30 LOW
Wee (Beng Geok) Individual Investor 0.1892 3564000 -20000 2023-03-21

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Raffles Medical Company profile

Track the Raffles Medical share price today and spot the best levels for profitable CFD trades

Raffles Medical Group Ltd is a full spectrum health services company founded in Singapore in 1976. The company served over 2 million clients in 2020 with operations in 14 cities across five countries. As with many other companies, Raffles Medical initially suffered greatly from closures enacted due to the coronavirus pandemic. The company was unable to offer any non-essential health services which form a large part of its revenue.

After an initial period of closures the company was able to devise new income streams through providing Covid testing to migrant workers and other travellers entering the Southeast Asian countries where they have operations. The company is currently the largest private health care services provider in Singapore.

Raffles Medical stock price was listed on the Singapore Stock Exchange mainboard on April 11, 1997 and trades under the ticker symbol BSL. Raffles Medical operates three primary business lines. The first is healthcare, which offers insurance services, pharmaceutical products and services as well as aftercare coverage for patients. The hospital division offers emergency and surgery services as well as medical devices for patient use. Finally the company has an active investment division, primarily dealing with the real estate holdings of the group.

The Raffles Medical (BSL) stock has traded within the 52-week range of S$0.75 - S$1.14 at an average volume of close to 53 million shares per day. The stock began 2021 at S$0.995 before dipping to a low of S$0.925 near the end of January and then rising steadily to S$1.09 by late March.

BSL has a market capitalisation of just over $2 billion Singapore dollars and posted a net income of S$65 million in 2020. Revenues increased to S$568 million in 2020, up 8.8 per cent from the previous year.

The latest BSL stock chart is updated on the SGX as well as on Capital.com. By accessing the live price chart on Capital.com you can view the Raffles Medical Group share price in real time.

You can trade BSL now with CFDs and open a long or short position, depending on whether you feel the price will rise or fall. CFDs allow you to profit from upward or downward fluctuations in the Raffles Medical (SGX) stock price at Capital.com. Track the BSL stock price and include this Singapore-founded multinational medical services company in your investment portfolio.

Industry: Ambulance & Emergency Services

585 North Bridge Road
188770
SG

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

US100

17,914.30 Price
-0.300% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 7.0

Gold

2,035.76 Price
+0.560% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0103%
Overnight fee time 22:00 (UTC)
Spread 0.50

Oil - Crude

76.56 Price
-2.240% 1D Chg, %
Long position overnight fee 0.0163%
Short position overnight fee -0.0382%
Overnight fee time 22:00 (UTC)
Spread 0.030

BTC/USD

51,177.55 Price
+0.260% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading